These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 22985273)

  • 1. Adeno-associated virus serotype 8 gene therapy leads to significant lowering of plasma cholesterol levels in humanized mouse models of homozygous and heterozygous familial hypercholesterolemia.
    Kassim SH; Li H; Bell P; Somanathan S; Lagor W; Jacobs F; Billheimer J; Wilson JM; Rader DJ
    Hum Gene Ther; 2013 Jan; 24(1):19-26. PubMed ID: 22985273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-Clinical Study Examining AAV8.TBG.hLDLR Vector-Associated Toxicity in Chow-Fed Wild-Type and LDLR
    Greig JA; Limberis MP; Bell P; Chen SJ; Calcedo R; Rader DJ; Wilson JM
    Hum Gene Ther Clin Dev; 2017 Mar; 28(1):39-50. PubMed ID: 28319449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonclinical Pharmacology/Toxicology Study of AAV8.TBG.mLDLR and AAV8.TBG.hLDLR in a Mouse Model of Homozygous Familial Hypercholesterolemia.
    Greig JA; Limberis MP; Bell P; Chen SJ; Calcedo R; Rader DJ; Wilson JM
    Hum Gene Ther Clin Dev; 2017 Mar; 28(1):28-38. PubMed ID: 28319445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AAV vectors expressing LDLR gain-of-function variants demonstrate increased efficacy in mouse models of familial hypercholesterolemia.
    Somanathan S; Jacobs F; Wang Q; Hanlon AL; Wilson JM; Rader DJ
    Circ Res; 2014 Aug; 115(6):591-9. PubMed ID: 25023731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene therapy in a humanized mouse model of familial hypercholesterolemia leads to marked regression of atherosclerosis.
    Kassim SH; Li H; Vandenberghe LH; Hinderer C; Bell P; Marchadier D; Wilson A; Cromley D; Redon V; Yu H; Wilson JM; Rader DJ
    PLoS One; 2010 Oct; 5(10):e13424. PubMed ID: 20976059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biodistribution of AAV8 vectors expressing human low-density lipoprotein receptor in a mouse model of homozygous familial hypercholesterolemia.
    Chen SJ; Sanmiguel J; Lock M; McMenamin D; Draper C; Limberis MP; Kassim SH; Somanathan S; Bell P; Johnston JC; Rader DJ; Wilson JM
    Hum Gene Ther Clin Dev; 2013 Dec; 24(4):154-60. PubMed ID: 24070336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exosome-based
    Li Z; Zhao P; Zhang Y; Wang J; Wang C; Liu Y; Yang G; Yuan L
    Theranostics; 2021; 11(6):2953-2965. PubMed ID: 33456582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene therapy for rhesus monkeys heterozygous for LDL receptor deficiency by balloon catheter hepatic delivery of helper-dependent adenoviral vector.
    Oka K; Mullins CE; Kushwaha RS; Leen AM; Chan L
    Gene Ther; 2015 Jan; 22(1):87-95. PubMed ID: 25231173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A mouse model of human familial hypercholesterolemia: markedly elevated low density lipoprotein cholesterol levels and severe atherosclerosis on a low-fat chow diet.
    Powell-Braxton L; Véniant M; Latvala RD; Hirano KI; Won WB; Ross J; Dybdal N; Zlot CH; Young SG; Davidson NO
    Nat Med; 1998 Aug; 4(8):934-8. PubMed ID: 9701246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene therapy for familial hypercholesterolemia.
    Van Craeyveld E; Jacobs F; Gordts SC; De Geest B
    Curr Pharm Des; 2011; 17(24):2575-91. PubMed ID: 21774774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-density lipoprotein receptor-deficient hepatocytes differentiated from induced pluripotent stem cells allow familial hypercholesterolemia modeling, CRISPR/Cas-mediated genetic correction, and productive hepatitis C virus infection.
    Caron J; Pène V; Tolosa L; Villaret M; Luce E; Fourrier A; Heslan JM; Saheb S; Bruckert E; Gómez-Lechón MJ; Nguyen TH; Rosenberg AR; Weber A; Dubart-Kupperschmitt A
    Stem Cell Res Ther; 2019 Jul; 10(1):221. PubMed ID: 31358055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenotype interaction of apobec-1 and CETP, LDLR, and apoE gene expression in mice: role of apoB mRNA editing in lipoprotein phenotype expression.
    Nakamuta M; Taniguchi S; Ishida BY; Kobayashi K; Chan L
    Arterioscler Thromb Vasc Biol; 1998 May; 18(5):747-55. PubMed ID: 9598833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cholesterol-Lowering Gene Therapy Counteracts the Development of Non-ischemic Cardiomyopathy in Mice.
    Muthuramu I; Amin R; Postnov A; Mishra M; Aboumsallem JP; Dresselaers T; Himmelreich U; Van Veldhoven PP; Gheysens O; Jacobs F; De Geest B
    Mol Ther; 2017 Nov; 25(11):2513-2525. PubMed ID: 28822689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cholesterol-Lowering Gene Therapy Prevents Heart Failure with Preserved Ejection Fraction in Obese Type 2 Diabetic Mice.
    Aboumsallem JP; Muthuramu I; Mishra M; De Geest B
    Int J Mol Sci; 2019 May; 20(9):. PubMed ID: 31064116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sleeping Beauty Transposon Vectors in Liver-directed Gene Delivery of LDLR and VLDLR for Gene Therapy of Familial Hypercholesterolemia.
    Turunen TA; Kurkipuro J; Heikura T; Vuorio T; Hytönen E; Izsvák Z; Ylä-Herttuala S
    Mol Ther; 2016 Mar; 24(3):620-35. PubMed ID: 26670130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene therapy with novel adeno-associated virus vectors substantially diminishes atherosclerosis in a murine model of familial hypercholesterolemia.
    Lebherz C; Gao G; Louboutin JP; Millar J; Rader D; Wilson JM
    J Gene Med; 2004 Jun; 6(6):663-72. PubMed ID: 15170737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Construction of minicircle DNA vectors capable of correcting familial hypercholesterolemia phenotype in a LDLR-deficient mouse model.
    Hou X; Jiao R; Guo X; Wang T; Chen P; Wang D; Chen Y; He CY; Chen ZY
    Gene Ther; 2016 Aug; 23(8-9):657-63. PubMed ID: 27092942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A review of gene- and cell-based therapies for familial hypercholesterolemia.
    Hajighasemi S; Mahdavi Gorabi A; Bianconi V; Pirro M; Banach M; Ahmadi Tafti H; Reiner Ž; Sahebkar A
    Pharmacol Res; 2019 May; 143():119-132. PubMed ID: 30910740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Homozygous familial hypercholesterolaemia: update on management.
    France M
    Paediatr Int Child Health; 2016 Nov; 36(4):243-247. PubMed ID: 27967828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prolonged correction of hyperlipidemia in mice with familial hypercholesterolemia using an adeno-associated viral vector expressing very-low-density lipoprotein receptor.
    Chen SJ; Rader DJ; Tazelaar J; Kawashiri M; Gao G; Wilson JM
    Mol Ther; 2000 Sep; 2(3):256-61. PubMed ID: 10985956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.